JP2017176687A - Liquid smoke-emitting transpiration agent and method of using the same - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a liquid smoke-emitting transpiration agent that can be subjected to transpiration in the smoke form into the atmosphere by heating, as well as to provide a method for the transpiration of a chemical agent using the liquid smoke-emitting transpiration agent, and a chemical agent transpiration device used in the implementation of the method.SOLUTION: A liquid smoke-emitting transpiration agent has the following characteristics: (A) it is a liquid smoke-emitting transpiration agent containing a chemical agent and a solvent; (B) the solvent has a boiling point of 170°C or higher; (C) the average vapor pressure of the transpiration agent at 20°C is 0.1 to 10 Pa; and (D) the average molecular weight of soluble components contained in the transpiration liquid agent is from 150 to 250.SELECTED DRAWING: None

Description

  The present invention relates to a liquid fuming transpiration agent and a method of using the same. More specifically, the present invention relates to a liquid fuming transpiration agent that can be vaporized (evaporated) into the atmosphere (aerosol state) by heating, and a method of transpiration of a medicine using the liquid fuming transpiration agent. And a chemical vaporizer used to carry out the method. The “drug transpiration method” of the present invention can also be referred to as a method for treating a space with a drug.

  Conventionally, as a device for evaporating transpiration agents containing chemicals such as fragrances, deodorants, and insect repellents into indoor spaces, in addition to spray-type transpiration devices, natural evaporation types and stationary-type transpiration devices A heating type evaporator is known.

  In a natural evaporation type evaporator, a liquid evaporation agent containing a drug is placed as it is or impregnated in a core material made of a porous material to evaporate the evaporation agent in the indoor space. The amount of evaporation of the agent is small, and the effect of the agent may not be sufficiently exhibited in the indoor space. In the natural evaporation type evaporator, the evaporation agent containing the medicine is stored in an open container in contact with the outside air, so that the room temperature becomes high or the air in the room space is replaced. There is a problem that the disappearance of the transpiration agent is accelerated and the sustainability of the intended drug effect may not be guaranteed.

  On the other hand, as a heating-type evaporator, a transpiration agent containing a medicine is electrically heated when necessary to evaporate it actively, filling the interior of the medicine component efficiently, or evaporating in a smoke form. Electric heating evaporators that can be made are known. For example, as a transpiration device capable of evaporating the latter, specifically, the transpiration agent is evaporated in the form of smoke by heating a core impregnated with a liquid transpiration agent containing a medicine, and the evaporated transpiration agent. However, there is known a vaporizer configured so as to rise upward through a tunnel passage provided above the core (Patent Documents 1 and 2). Such a conventional electric heating type evaporator can increase the evaporation rate of the evaporation agent by energizing and heating at the time of use, and can obtain a desired effect efficiently. Similarly, since the transpiration agent is stored in an open container in contact with the outside air, it continues to evaporate even when it is not heated, and depending on the conditions in the indoor space, the evaporation of the transpiration agent is accelerated, and the agent can be used in a short period of time. There is a problem that the effect of disappears.

JP 2013-22163 A JP 2013-22164 A

  Against the background of the prior art as described above, conventionally, a transpiration agent containing a drug can be evaporated into the indoor space in a visible smoke state (ie, aerosol state) by heating at the time of use, while at the time of non-heating. By suppressing evaporation, even when the transpiration agent is always kept in contact with the open air in an open container, the early disappearance of the transpiration agent is suppressed and the drug transpiration can be obtained continuously. Technology development was sought.

  An object of the present invention is to solve the above-mentioned problems of the prior art. Specifically, when it is heated, it is evaporated into a space that can be visually recognized, and when it is not heated, the evaporation is suppressed so that it is always kept in contact with the outside air in an open container. Even in this case, it is to provide a liquid fuming transpiration agent in which early disappearance is suppressed. Moreover, the subject of this invention is providing the usage method (application) of the said liquid fuming transpiration agent. Specifically, it is an object of the present invention to provide a method of evaporating a drug using the liquid fuming evaporative agent or a space treatment method using an agent, and a drug evaporator used in the method.

The present inventor has intensively studied to solve the above-mentioned problems. In the liquid fuming transpiration agent containing (A) the drug and the solvent, (B) the boiling point of the solvent is 170 ° C. or higher, and (C) liquid The above-mentioned problems were solved by setting the average vapor pressure of the fuming transpiration agent at 20 ° C. to 0.1 to 10 Pa and (D) the average molecular weight of the soluble component contained in the liquid fuming transpiration agent to 150 to 250. It has been found that a liquid fuming transpiration agent is obtained. Specifically, the liquid fuming transpiration agent is evaporated at room temperature in a visible smoke state (ie, aerosol state) by heating at a temperature of 100 ° C. or higher. Even when the agent is stored in an open container in contact with the outside air, the evaporation of the transpiration agent is significantly suppressed, and as a result, the early disappearance of the effect of the agent is suppressed, and the desired sustainability is achieved. I found that I can maintain it.
The present invention has been completed by further studies based on this finding.

That is, the present invention provides the following aspects.
(I) Liquid fuming transpiration agent (I-1) (A) A liquid fuming transpiration agent containing a drug and a solvent,
(B) the boiling point of the solvent is 170 ° C. or higher,
(C) The average vapor pressure of the transpiration liquid at 20 ° C. is 0.1 to 10 Pa, and (D) the average molecular weight of the soluble component contained in the transpiration liquid is 150 to 250,
A liquid fuming transpiration agent, characterized in that
(I-2) The liquid fuming transpiration agent according to (I-1), wherein the solvent has a boiling point of 170 ° C. to 350 ° C.
(I-3) (I-1) or (I-2), wherein the solvent is at least one selected from the group consisting of alcohol solvents, glycol ether solvents, glycol solvents, and hydrocarbon solvents. ) The liquid fuming transpiration agent described in the above.
(I-4) The above solvent is 3-methoxy-3-methyl-1-butanol, benzyl alcohol, dipropylene glycol monomethyl ether, tripropylene glycol monomethyl ether, dipropylene glycol n-propyl ether, dipropylene glycol n-butyl ether. At least one selected from the group consisting of diethylene glycol n-butyl ether, tripropylene glycol n-butyl ether, dipropylene glycol methyl ether acetate, propylene glycol phenyl ether, propylene glycol, ethylene glycol, hexylene glycol, dipropylene glycol, and diethylene glycol The liquid fuming transpiration agent according to any one of (I-1) to (I-3), which is a seed.
(I-5) The drug contains at least one selected from the group consisting of a fragrance component, a deodorant component, an insecticidal component, an antibacterial component, and an insect repellent component (I-1) to (I- The liquid fuming transpiration agent according to any one of 4).
(I-6) The liquid fuming transpiration agent according to any one of (I-1) to (I-5), wherein the mixing ratio of the solvent contained in the liquid fuming transpiration agent is 10 to 99.9% by weight. .
(I-7) A core material obtained by impregnating a porous base material with the liquid fuming transpiration agent according to any one of (I-1) to (I-6).
(I-8) The core material composed of the porous substrate is selected from the group consisting of glass fiber, carbon fiber, fiber kneaded with acrylic fiber and melamine resin, and PEEK (polyether ether ketone) fiber. The core material according to (I-7), which is at least one kind.
(I-9) The liquid fuming transpiration agent according to any one of (I-1) to (I-6), which is sealed in a package having liquid tightness and air tightness, or (I -7) or the core material described in (I-8).

(II) The liquid fuming transpiration agent according to any one of the chemical transpiration method or the space treatment method (II-1) (I-1) to (I-6), or a porous substrate impregnated with the liquid smoking transpiration agent. A chemical transpiration method or a chemical space treatment method comprising a step of evaporating the liquid fuming transpiration agent into a smoke form by supplying the core material to a heating element that generates heat to 100 ° C. or more when energized and heating.
(II-2) The chemical transpiration method or the chemical space treatment method according to (II-1), wherein the heating element generates heat at 100 to 350 ° C. when energized.
(II-3) In (II-1) or (II-2), the boiling point of the solvent contained in the liquid fuming transpiration agent is 170 to 350 ° C., and the exothermic temperature of the heating element is 100 to 350 ° C. A method for transpiration of a medicine or a method for spatial treatment with a medicine.

(III) a core material impregnated with the liquid fuming transpiration agent described in any one of the chemical vaporizer (III-1) (I-1) to (I-6);
Having a heating element that is energized and generates heat above 100 ° C .;
The heating element is disposed so as to be in contact with or close to the core material at least when energized, and heats the core material to evaporate the liquid fuming transpiration agent absorbed in the core material in a smoke form.
Drug evaporator.
(III-2) a container containing the liquid fuming transpiration agent described in any of (I-1) to (I-6);
Inserted into the container, sucking up the liquid fuming transpiration agent from the container, and impregnating the core,
Having a heating element that is energized and generates heat above 100 ° C .;
The heating element is disposed so as to be in contact with or close to the core material at least when energized, and heats the core material to evaporate the liquid fuming transpiration agent absorbed in the core material in a smoke form.
Drug evaporator.
(III-3) The chemical vaporizer described in (III-1) or (III-2), wherein the heating element is energized and heated to 100 ° C to 350 ° C.
(III-4) The liquid fuming transpiration agent contains at least a fragrance component having an incense scent as a medicine, and is used as an electric pseudo-incense device (III-1) to (III-3) ) Chemical vaporizer.

  Moreover, the chemical vaporizer of this invention includes the chemical vaporizer of the aspect concretely shown by FIGS. The chemical vaporizer can be specifically described as the following modes A and B.

(Aspect A)
(III-A-1) a container containing a liquid fuming transpiration agent;
A core material inserted into the container and sucking up the liquid fuming transpiration agent from the container;
A heating section for heating the core material and evaporating the liquid fuming transpiration agent absorbed in the core material into a smoke;
Defining a tunnel passage through which the smoke-like liquid fuming transpiration agent passes, and having a tunnel entrance of the tunnel passage at the lower end and a tunnel member having a tunnel exit of the tunnel passage at the upper end,
The container is located below the tunnel entrance, and after receiving condensation in the tunnel passage, a tray for receiving the liquid fuming transpiration agent in liquid form falling from the tunnel passage through the tunnel entrance. Part
A liquid return passage communicating with the internal space of the container is formed in the dish portion.
Drug evaporator.
(III-A-2) The dish portion has a bottom surface portion that defines the upper surface of the internal space and an outer peripheral wall that stands along the outer periphery of the bottom surface portion, and the liquid return passage is provided in the bottom surface portion. The chemical vaporizer according to (III-A-1), in which an opening is formed.
(III-A-3) further comprising a wall member disposed so as to extend between the tunnel entrance and the container while enclosing the tunnel entrance;
The volatilization according to (III-A-1) or (III-A-2), wherein the wall member is formed with an air suction port for sending air into the tunnel passage through the tunnel entrance. vessel.
(III-A-4) further comprising a wall member arranged to extend between the tunnel entrance and the container while enclosing the tunnel entrance,
The wall member is formed with an air inlet for sending air into the tunnel passage through the tunnel entrance,
The chemical vaporizer according to (III-A-2), wherein an outer surface of the wall member is in contact with an inner peripheral surface of the outer peripheral wall of the dish portion.
(III-A-5) The structure according to (III-A-3) or (III-A-4), further including a biasing member that biases the container against the tunnel member through the wall member. Drug evaporator.
(III-A-6) The tunnel member has an inner wall surface that defines the tunnel passage, and a convex portion that protrudes inward from the inner wall surface. (III-A-1) to (III -The chemical vaporizer in any one of A-5).
(III-A-7) The chemical vaporizer according to (III-A-6), wherein the convex portion extends continuously from the vicinity of the tunnel exit to at least the vicinity of the tunnel entrance.

(Aspect B)
(III-B-1) a container containing a liquid fuming transpiration agent;
A core material inserted into the container and sucking up the liquid fuming transpiration agent from the container;
A heating section for heating the core material and evaporating the liquid fuming transpiration agent absorbed in the core material into a smoke;
The tunnel is located above the container at a predetermined interval, defines a tunnel passage through which the smoke-like liquid fuming transpiration agent passes, and has a tunnel entrance of the tunnel passage at a lower end, and the tunnel at an upper end. A tunnel member having a tunnel exit of the passage;
A wall member disposed so as to extend between the tunnel entrance and the container while enclosing the tunnel entrance;
The chemical vaporizer, wherein the wall member is formed with an air inlet for sending air into the tunnel passage through the tunnel inlet.
(III-B-2) The wall member is disposed so as to extend between the tunnel inlet and the container while leaving a gap serving as the air inlet along the circumferential direction of the tunnel inlet. The chemical vaporizer as described in (III-B-1).
(III-B-3) The tunnel member has an inner wall surface that defines the tunnel passage, and a convex portion that protrudes inward from the inner wall surface. (III-B-1) or (III -The chemical vaporizer as described in B-2).
(III-B-4) The chemical vaporizer according to (III-B-3), wherein the convex portion extends continuously from the vicinity of the tunnel exit to at least the vicinity of the tunnel entrance.
(III-B-5) The chemical vaporizer according to (III-B-3) or (III-B-4), wherein the convex portion does not reach the center in a cross-sectional view of the tunnel passage.
(III-B-6) The tunnel member has a plurality of convex portions that respectively protrude from different positions along the circumferential direction of the inner wall surface. (III-B-3) to (III-B-5) The chemical vaporizer in any one of.
(III-B-7) The chemical vaporizer according to (III-B-6), wherein the plurality of convex portions are arranged at approximately equal intervals along the circumferential direction.
(III-B-8) The chemical vaporizer according to any one of (III-B-1) to (III-B-7), wherein the wall member is formed integrally with the tunnel member.
(III-B-9) The heating unit is disposed below the center along the direction in which the tunnel passage extends in the tunnel passage, and has a heating element that generates heat when energized. The chemical vaporizer according to any one of B-1) to (III-B-8).

  According to the present invention, a liquid fuming transpiration that evaporates rapidly under heating conditions, while evaporation is significantly suppressed even when stored in an open container in contact with outside air under non-heating conditions. An agent can be provided. Specifically, the liquid fuming transpiration agent of the present invention is heated to a temperature of 100 ° C. or higher when necessary, and evaporates into the indoor space as a visible smoke state (that is, an aerosol state) to enter the indoor space. While it is possible to evaporate the drug, it is possible to significantly suppress its evaporation (suppression of natural evaporation) by setting it to a non-heated state when not required. Thus, according to the liquid fuming transpiration agent of the present invention and the transpiration method using the same, it is possible to control the on / off of the evaporation of the drug by switching between heating and non-heating (energization and non-energization). In addition, it is possible to treat the space with the drug while suppressing the early disappearance of the drug effect due to natural evaporation and maintaining the desired sustainability.

  Moreover, the chemical vaporizer of the present invention using a liquid fuming vaporizer containing a fragrance component having an incense scent as a chemical can be used as an electrothermal pseudo-incense device. Specifically, when not in use, the current is turned off and kept in a non-heated state to suppress the evaporation of the liquid fuming transpiration agent. Then, the liquid fuming transpiration agent impregnated in the core material can be heated and quickly evaporated to release white smoke-like pseudo-incense. As described above, according to the present invention, by switching between energization and non-energization (heating and non-heating), it is possible to easily control the on / off of the white smoke emission of the pseudo incense stick and to suppress the early disappearance of the incense stick effect due to natural evaporation. Thus, a desired effect can be obtained continuously.

It is a figure which shows an example of the principal part structure of the chemical vaporizer of this invention. It is a figure which shows an example of the principal part structure of the chemical vaporizer of this invention. The perspective view of the chemical vaporizer in the use condition which concerns on one Embodiment of this invention. The side view of the main-body part of the state which opened the flap member. The perspective view of the main-body part which abbreviate | omitted the flap member. The perspective view which shows a mode that the container of the evaporation liquid agent was accommodated in the main-body part of FIG. The perspective view of a container with a cap. The perspective view of a container without a cap. FIG. 4 is a cross-sectional view taken along line AA in FIG. 3 near the container. The perspective view which looked at the flap member from the upper surface side. The perspective view which looked at the flap member from the lower surface side. The bottom view of a tunnel member, a convex member, and a wall member. The typical longitudinal section of the tunnel passage neighborhood for explaining the role of a convex part. BB sectional drawing of FIG. The perspective view which looked at the upper housing | casing from the bottom face side. The block diagram which shows the electrical structure of a chemical | medical vaporizer. The bottom view of a chemical evaporator. The bottom view of the tunnel member which concerns on a modification, a convex member, and a wall member.

(I) Liquid fuming transpiration agent The liquid fuming transpiration agent of the present invention (hereinafter also simply referred to as “transpiration liquid agent”) has the following characteristics.
(A) Contains a drug and a solvent.
(B) The boiling point of the solvent is 170 ° C. or higher.
(C) The average vapor pressure of the transpiration liquid at 20 ° C. is 0.1 to 10 Pa.
(D) The average molecular weight of the soluble component contained in the transpiration liquid is 150 to 250.

  Hereinafter, these features will be described. In the present specification, the term “smoke (or aerosol)” means a state in which the evaporation liquid containing the drug evaporates is visually recognized like incense smoke, and “liquid fuming evaporation ( "Smokeable transpiration liquid agent" means a liquid composition that emits smoke when the liquid agent evaporates, and the smoke is visually recognized like incense smoke.

  The solvent used in the transpiration liquid of the present invention may be any solvent that has a boiling point of 170 ° C. or higher and can be used for transpiration into space. For example, alcohol solvents, glycol ether solvents, glycol solvents, and hydrocarbons. Examples thereof include system solvents. Although not limited, specific examples of the solvent include alcohol solvents such as 3-methoxy-3-methyl-1-butanol (boiling point 174 ° C.) and benzyl alcohol (boiling point 205 ° C.); dipropylene glycol monomethyl ether ( 190 ° C boiling point), tripropylene glycol monomethyl ether (bp 242 ° C), dipropylene glycol n-propyl ether (bp 212 ° C), dipropylene glycol n-butyl ether (bp 229 ° C), tripropylene glycol n-butyl ether (bp 274) ), Dipropylene glycol methyl ether acetate (boiling point 209 ° C.), propylene glycol phenyl ether (boiling point 243 ° C.), diethylene glycol monobutyl ether (butyl carbitol) (boiling point 230 ° C.), etc. Solvents: propylene glycol (boiling point 178 ° C), propylene glycol (boiling point 187 ° C), ethylene glycol (boiling point 198 ° C), hexylene glycol (boiling point 198 ° C), dipropylene glycol (boiling point 232 ° C), diethylene glycol (boiling point 244 ° C) ) And the like; and hydrocarbon solvents such as isoparaffin and normal paraffin. These solvents may be used alone or in any combination of two or more.

  Here, the “space” includes an indoor space; an indoor space; a vehicle interior space; a closed space inside a closet, a closet or a shoebox, etc .; an open space outdoors.

  Among these solvents, glycol-based solvents are preferably used in order to improve the ability to form smoke (aerosol). Among the glycol solvents, dipropylene glycol-n-butyl ether, diethylene glycol monobutyl ether, and dipropylene glycol are preferable.

  In the transpiration liquid agent of the present invention, the blending ratio of the solvent is not particularly limited as long as the requirements (C) and (D) described later are satisfied, and is, for example, 10 to 99.100 per 100% by weight of the transpiration liquid agent. It can select suitably from the range of 9 weight%. In order to further enhance the function of evaporating the transpiration liquid in the form of visible smoke (that is, aerosol), the blending ratio of the solvent in the transpiration liquid should be set in the range of 25 to 99.9% by weight. Is preferred. More preferably, it is 30 to 80% by weight.

  In the transpiration liquid of the present invention, depending on the desired function (effect) that is exhibited when the transpiration liquid is transpirated into the space, a fragrance component, a deodorizing component, an insecticidal component (including an acaricidal component), Pharmaceutical components such as antibacterial components and insect repellent components are blended. About such a chemical | medical component, as long as it can evaporate in air | atmosphere (air) in the environment used, and satisfy | fills the requirements of said (C) and (D) mentioned later, either oily or aqueous | water-based Good. Although not limited, the transpiration liquid used in the present invention is a fragrance when it contains a fragrance component as a drug component, and as a deodorant when it contains a deodorant component, a fragrance and When it contains a deodorant component, as an aromatic deodorant, when it contains an insecticide component (acaricide component), as an insecticide (acaricide), when it contains an antibacterial component, And an insect repellent component, each is used as an insect repellent solution.

  The transpiration liquid of the present invention can be suitably used for giving a fragrance effect or / and a deodorizing effect to a space (preferably an indoor space) by evaporating a fragrance component or / and a deodorizing component. Furthermore, an antibacterial component can also be mix | blended as a chemical | medical agent component, and in addition to the said aromatic effect or / and a deodorizing effect, an antibacterial effect can be provided to space (preferably indoor space) by doing in this way. For this reason, as a chemical | medical agent component used by this invention, Preferably, at least 1 type selected from the group which consists of a fragrance | flavor component, a deodorizing component, and an antimicrobial component can be mentioned. In the examples to be described later, as an example of the embodiment of the fuming transpiration liquid agent of the present invention, an embodiment containing an aromatic liquid having an scent of burning incense (incense of incense) is shown.

  About the fragrance | flavor component mix | blended with the transpiration | evaporation liquid agent of this invention, any of a natural fragrance | flavor, the isolated fragrance | flavor isolate | separated from the natural fragrance | flavor, and a synthetic fragrance | flavor may be sufficient, The well-known fragrance | flavor component currently used for the conventional fragrance | flavor Can be used. Specific examples of the fragrance component include aldehydes having 6 to 12 carbon atoms, anisaldehyde, acetal R, acetophenone, acetyl cedrene, adoxal, allyl amyl glycolate, allyl cyclohexane propionate, alpha damascone, amblet lid, Ambroxan, amylcinnamic aldehyde, amylcinnamic aldehyde dimethyl acetal, amyl valericate, amyl salicylate, isoamyl acetate, acetyl yugenol, isoamyl salicylate, indole, α ionone, β ionone, α methyl ionone, β methyl ionone, γ methyl ionone, indene , Ethyl alliline, uranium thiol, oak moss No. 1, olibon, oxyphenylone, caryophyllene, cashmerelan, carvone, galaxo , Caron, coumarin, paracresyl methyl ether, geraniol, geranyl acetate, geranyl formate, geranyl nitrile, tetrahydrogeraniol, tetrahydrogeranyl acetate, coabon, sandaroa, sandera, santa rex, santalinol, methyl salicylate, cinnamic Alcohol, cinnamic aldehyde, cis jasmon, citral, citral dimethyl acetal, citrusal, citronellal, citronellol, citronellyl acetate, citronellyl formate, citronellil nitrile, cyclaset, cyclamenaldehyde, cyclaprop, cinnamyl acetate, dihydrojasmon, Dimethol, isocyclocitral, jasmar, jasmolactone, jasmo Filan, styryl reel acetate, styryl propionate, cedro amber, cedol acetate, cedrol, celestrido, β damascone, α terpineol, γ terpineol, tarpinyl acetate, thymol, delta damascon, delta C6-C13 Lactone, tonalid, traseolide, tripral, isononyl acetate, nerol, neryl acetate, neobergamate, nopelacetate, nopele alcohol, bacdanol, hyacinth dimethyl acetal, hydrotropic alcohol, hydroxycitronellal, alpha pinene, butyl butyrate Rate, para tertiary butyl cyclohexanol, para tertiary butyl cyclohexyl acetate, ortho tertiary butyl cyclohexanol, di Phenyl oxide, fluitate, phenthyl alcohol, phenyl ethyl phenyl acetate, isobutyl quinoline, phenyl ethyl alcohol, phenyl ethyl acetate, phenyl acetoaldehyde dimethyl acetal, benzyl acetate, benzyl alcohol, benzyl salicylate, bergamyl acetate, benzaldehyde, benzyl formate, Dimethylbenzylcarbinol, hedion, helional, heliotropin, cis-3-hexenol, cis-3-hexenyl acetate, cis-3-hexenyl salicylate, hexylcinnamic aldehyde, hexyl salicylate, pentalide, bellox, ortho Bornyl acetate, isobornyl acetate, isoborneol, endo-borneo , Manzanate, mayol, mugealdehyde, miracaldehyde, dihydromyrsenol, dimyrcetol, mugor, musk TM-II, musk 781, musk C14, musk T, musk ketone, musk civetine, musk mosken, mensanil acetate, mensonate, methyl Anthranilate, Methyl Yugenol, Menthol, Methyl Phenyl Acetate, Yugenol, Iso Yugenol, Methyl Iso Yugenol, γC 6-13 Lactone, Lime Oxide, Methyl Lavender Ketone, Dihydrolinalol, Ligstral, Lilyal, Limonene, Linalool, Linalool Oxide, Tetrahydro Linalool, tetrahydrolinalyl acetate, linalyl acetate, rilal, rubafuran, rosephenone, rose o Kide, crocodile, benzoin, perubalsum, trubalsum, tuberose oil, mustin tincture, castrium tincture, civet tincture, ambergris tincture, peppermint oil, perilla oil, petitgren oil, pine oil, rose oil, rosemary oil, bran oil , Good oil, clary sage oil, sandalwood oil, spearmint oil, spike lavender oil, star anise oil, lavandin oil, lavender oil, lemon oil, lemongrass oil, lime oil, neroli oil, oak moss oil, okothia oil, patchouli oil, Thyme oil, tonka bean tincture, turpentine oil, vanilla bean tincture, basil oil, nutmeg oil, citronella oil, clove oil, bored rose oil, cananga oil, cardamom oil, cassia oil, cedarwood oil, orange oil, mandarin oil, tangerine oil, anise Bay oil, coriander oil, elemi oil, eucalyptus oil, fennel oil, galvanum oil, geranium oil, hiba oil, cocoon oil, jasmine oil, vetiver oil, bergamot oil, ylang ylang oil, grapefruit oil, yuzu oil, etc. Can do. These perfume ingredients may be used alone or in combination with any combination of two or more.

  Further, examples of the deodorant component to be blended in the transpiration liquid of the present invention include plant extracts such as rice, pine, hinoki, persimmon and green tea; fourth examples such as alkylbenzyldimethylammonium salt and didecyldimethylammonium salt. Quaternary ammonium salts; Heterocyclic compounds such as cetylviridinium salts and benzoisothiazolines; Silver compounds such as silver oxide, silver-containing water-soluble glass, silver-supported zeolite, silver nanoparticles, silver ions, silver nitrate, and silver sulfide Metal compounds such as zinc oxide, copper oxide, zinc ions, copper ions and gold nanoparticles; clathrate compounds such as cyclodextrin and cyclophane; amphoteric compounds such as amphoteric surfactant deodorants and amino acid deodorants A fine powder of an adsorbing material such as silica gel, alumina, activated carbon or zeolite. These deodorant components may be used alone or in any combination of two or more.

  Antibacterial components blended in the transpiration liquid of the present invention include, for example, octyltrimethylammonium chloride, didecyldimethylammonium gluconic acid, chlorhexidine, chlorhexidine gluconate, allyl isothiocyanate, propylene glycol monomethyl ether, propylene glycol monopropyl ether and the like. Can be mentioned. These antibacterial components may be used alone or in any combination of two or more.

  Examples of the insecticidal component (acaricidal component) blended in the transpiration liquid of the present invention include, for example, parathion, dichlorvos, malathion, fenitrothion, dichlorodiphenyltrichloroethane, pyrethrin, permethrin, imiproslin, etofenprox, imidacloprid, acetamiprid, dinotefuran, carbaryl , Propoxer, fenob curve and the like. These insecticidal components (miticidal components) may be used alone or in any combination of two or more.

  Examples of the insect repellent component blended in the transpiration liquid of the present invention include, for example, DEET, pisabolol, isopine pinerin, bergabbutene, xanthotoxin, coxagine, dihydrocoxagine, dimethyl terephthalate, diethyl terephthalate, N, N-diethyl-m-toluamide , Dimethyl phthalate, dibutyl phthalate, p-menthane-3,8-diol, 2-ethyl-1,3-hexanediol, di-n-propylisocincomellonate, p-dichlorobenzene, di-n-butyl Examples include succinate, caran-3,4-diol, 1-methylpropyl-2- (2-hydroxyethyl) -1-piperidinecarboxylate, and allyl isothiocyanate. Furthermore, terpene hydrocarbon fragrance | flavor, terpene alcohol fragrance | flavor, phenol fragrance | flavor, aromatic alcohol fragrance | flavor, aldevid fragrance | flavor, mustard, wasabi, plant extracts, wood vinegar liquid, etc. are mentioned. These insect repellent components may be used alone or in any combination of two or more.

  These pharmaceutical ingredients (fragrance ingredient, deodorant ingredient, insecticide ingredient, antibacterial ingredient, and insect repellent ingredient) may be used alone or in any combination of two or more.

  In the transpiration liquid of the present invention, the blending ratio of the drug component is changed from 0.01 to 90% by weight to the type of the component on condition that the requirements (C) and (D) described later are satisfied. It can be set accordingly. Preferably it is 1 to 75 weight% of range.

  Moreover, the transpiration liquid of the present invention is water, ethanol, etc., as long as it satisfies the requirements of the above (C) and (D) described below, in addition to the solvent and chemicals described above, within a range not impeding the effects of the present invention. Drug component solubilizers; nonionic surfactants (eg polyoxyethylene alkyl ethers, polyoxyethylene hydrogenated castor oil), anionic surfactants, amphoteric surfactants, etc .; 1,2-benzisothiazoline An appropriate amount of preservatives such as -3-one and 2n-octyl-isothiazolin-3-one; antioxidants; ultraviolet absorbers; pigments such as pigments and dyes; and additives such as silicone may be contained.

  The transpiration liquid of the present invention is characterized in that the average vapor pressure at 20 ° C. of the final liquid is 10 Pa or less. The average vapor pressure is preferably 0.1 to 10 Pa, more preferably 0.1 to 5 Pa.

Here, the average vapor pressure means the average value of the vapor pressure at 20 ° C. of all the components contained in the transpiration liquid of the present invention, and can be specifically obtained from the calculation formula from the vapor pressure of each component (theory). value). The vapor pressure of each component can be obtained according to the OECD test guideline, and can be obtained from the vapor pressure information published on the chemical substance safety data sheet (MSDS) for each component. Specifically, for example, the transpiration liquid is composed of 30% by weight of an A component having a vapor pressure α at 20 ° C., 10% by weight of a B component having a vapor pressure β and 60% by weight of a C component having a vapor pressure γ. The average vapor pressure can be calculated from the following equation:

The transpiration liquid of the present invention is characterized in that the average molecular weight of the soluble component contained therein is 150 to 250. The average molecular weight is preferably 150 to 200.
Here, the average molecular weight means the average value of the molecular weights of the soluble components contained in the transpiration liquid of the present invention. Specifically, the average molecular weight can be obtained by calculation from the molecular weight of the soluble component contained in the transpiration liquid agent and its blending ratio (weight ratio). For example, the soluble components contained in the transpiration liquid are the A component (molecular weight α), the B component (molecular weight β), and the C component (molecular weight γ), and the total amount of the A to C components is 100 parts by weight. When the weight ratio is A component: 30 parts by weight, B component: 10 parts by weight, and C component: 60 parts by weight, the average molecular weight can be calculated from the following formula:

  Here, the soluble component means a component that can be dissolved in a target transpiration liquid (liquid transpiration) (20 ± 5 ° C.). Whether or not it can be dissolved can be determined based on the determination method and criteria of solubility defined by the Japanese Pharmacopoeia. Specifically, when the target component is solid, it can be judged from the extent that it is dissolved within 30 minutes when it is put into a solvent after being powdered, and shaken strongly every 5 minutes at 20 ± 5 ° C. for 30 seconds, In this case, it is judged that it is “slightly insoluble” (the amount of solvent required to dissolve 1 g or 1 ml of solute is 30 ml or more and less than 100 ml) and “very soluble” (the amount of solvent required to dissolve 1 g or 1 ml of solute is less than 1 ml). Can be mentioned. That is, when evaluated by the above method, it is possible to determine that a component in which the amount of solvent required to dissolve 1 g or 1 ml of solute is less than 100 ml is a soluble component. In addition, “dissolved (dissolved, dissolved)” in a solvent means that the target component is clearly dissolved or mixed in the solvent, and a fibrous substance or the like is not recognized in the dissolved solution. It means that.

  The transpiration liquid of the present invention has the above-mentioned solvent and chemicals, as necessary, so that the average vapor pressure at 20 ° C. of the final liquid is 0.1 to 10 Pa, and the average molecular weight of the soluble component is 150 to 250. It can be prepared by appropriately selecting and blending various components. Moreover, the transpiration liquid agent of the present invention is accommodated in a cylindrical round-mouthed bottle having a circular opening having a diameter of 2 mm and kept in a constant temperature and humidity condition (27 ° C., 60%) in the opened state. When left for 2 months, it is preferable to adjust so that the decrease after 2 months is 5% by weight or less of the initial total amount. Preferably, the amount of decrease after 2 months is 4% by weight or less of the initial total amount, more preferably 3% by weight or less.

  The transpiration liquid of the present invention is used by supplying it to a heating element when it is desired to evaporate the transpiration liquid and a drug component contained therein into the atmosphere (space). Here, the supply of the transpiration liquid agent to the heating element means that the transpiration liquid agent is brought into contact with or close to the heating element in the air atmosphere (in the air in the space). In order to efficiently transmit the heat of the heating element to the transpiration liquid agent and increase the evaporation amount of the transpiration liquid agent (evaporation amount in the form of smoke), it is preferable to bring the transpiration liquid agent into contact with the heating element.

  In this case, the transpiration liquid may be dropped (below the droplet) as it is on the heating element, or may be applied. In addition, the method and means used under a droplet should just be the method and means which can dripping a transpiration | evaporation liquid agent on a heat generating body, and the mechanism in particular is not restrict | limited. Similarly, the application method and means may be any method and means capable of applying the transpiration liquid on the heating element, and the mechanism and the like are not particularly limited.

  The transpiration liquid may be brought close to or in contact with the heating element through a core material impregnated with a porous substrate. In addition, as the one aspect | mode, the said core material is inserted and used for the container (container) which accommodated the evaporation liquid agent in the chemical | medical agent evaporation apparatus of this invention so that it may mention later. By doing so, as long as the transpiration liquid remains in the container, the core material can be used in a state where the transpiration liquid is sucked up from the container by the capillary action and impregnated with the transpiration liquid.

  As a porous substrate that can be used for the preparation of the core material impregnated with the transpiration liquid agent, as long as it can impregnate the transpiration liquid agent of the present invention and has heat resistance that can withstand the heating by the heating element, The material is not particularly limited. More preferably, it is made of a material that absorbs the transpiration liquid and can suck it up by capillary action. Examples of such a porous substrate material include glass fiber, carbon fiber, fiber in which acrylic fiber and melamine resin are kneaded, and PEEK (polyether ether ketone) fiber. Glass fiber and carbon fiber are preferable.

  The supply of the transpiration liquid agent to the heating element through the core material is desirably made to contact at least a part of the core material impregnated with the fuming transpiration liquid agent with the heating element. You may carry out by maintaining at least one part of material in the state which adjoined the heat generating body.

  The core material may be obtained by impregnating the porous substrate with a predetermined amount of the transpiration liquid of the present invention in advance, or the transpiration liquid can be sucked into the container (container) containing the transpiration liquid by capillary action. It may be configured such that the transpiration liquid agent is continuously supplied to the core material portion that is inserted in a state in contact with or close to the heating element.

  As the shape of the core material, as shown in FIGS. 1 and 2, a rod shape (cylindrical shape) in which both ends and the body portion have substantially the same cross-sectional shape and size can be exemplified. However, it can be set as appropriate depending on the supply method to the heating element. Moreover, the magnitude | size can be suitably set according to the quantity of the transpiration | evaporation liquid agent to impregnate, the raw material of a core material, the magnitude | size of the transpiration device mentioned later, etc. Although not limited, for example, in the case of the columnar shape, a diameter of 1 to 10 mm, preferably 1 to 3 mm; a length of 10 to 50 mm, preferably 20 to 30 mm can be exemplified. As shown in FIGS. 1 and 2, the core material may be held on the support. In this case, the exposed portion from the support is not limited, but is exemplified by 1 to 10 mm, preferably 5 to 10 mm. Can do.

  The transpiration liquid of the present invention is preferably used by being housed in a container (container) in which a core material is inserted as described above. Since the transpiration liquid is a consumable product in itself, it is independently subject to commercial transactions as a “refill product”. In addition, the core material impregnated with the transpiration liquid of the present invention is also subject to commercial transactions independently as a “refill product”. In addition, the core material impregnated with the transpiration liquid agent can be used as a “refillable product” as an object of commercial transaction together with the support body that holds the core material or is fixed to the container of the chemical transpiration device. For this reason, the said transpiration | evaporation liquid agent and the core material (it contains the core material hold | maintained at the support body) impregnated with it are each accommodated in the airtight and liquid-tight sealed containers (packaging body), and was sealed. It can be distributed to the market in a state. The hermetic and liquid-tight sealed container (packaging body) is not particularly limited as long as it has air-tightness or liquid-tightness so that the transpiration liquid does not volatilize or leak out. . Examples thereof include a resin bottle having liquid-tightness and airtightness, a pouch formed from a resin sheet, and the like.

2. The chemical evaporation method of the present invention can be carried out by supplying a liquid containing a chemical and a solvent having a boiling point of 170 ° C. or higher to a heating element that generates heat to a temperature of 100 ° C. or higher. By carrying out like this, the said liquid agent and the chemical | medical agent contained in it can be evaporated (transpiration) to air | atmosphere (space) like smoke. Here, examples of the liquid agent include the above-described liquid fuming vaporizer (fuming vaporizer) of the present invention, and the solvent and the chemical contained therein are also as described above.

  The supply of the transpiration liquid agent to the heating element can be carried out by bringing the transpiration liquid agent into contact with or close to the heating element, as described above. Specifically, it is possible to exemplify the application under the droplet or application of the transpiration liquid onto the heating element. Moreover, you may implement by making the core material prepared by impregnating a transpiration | evaporation liquid agent in a porous base material contact or adjoin to a heat generating body.

  The heating element used for heating the transpiration liquid may be anything that can be heated to a predetermined temperature, but an electric heating element that generates heat by energization is preferably used. The heat generation of the electric heating element can be canceled by cutting off (turning off) energization. Examples of such an electric heating body include a heating wire, a PTC heater, a ceramic heater, and a fixed resistance heater. When power is applied in a battery type, a heating wire is preferable from the viewpoint of power consumption.

  In the present invention, in the air atmosphere (in the air in the space), the transpiration solution supplied to the heating element is heated by the heating element that generates heat to 100 ° C. or more by energization, so that the heated transpiration solution forms an aerosol. It will be transpirationable with visible smoke. When heating the core material impregnated with the transpiration liquid agent, the transpiration liquid agent forms an aerosol at the contact portion of the core material and the heating element or in the vicinity of the core material and the heating element, and is in a visible smoke form. It becomes possible to evaporate.

  In the present invention, the temperature at which the heating element generates heat when energized is not particularly limited as long as it is 100 ° C. or higher, but from the viewpoint of improving the ability to form smoke (aerosol) while providing indoor use safety. Is preferably 100 to 350 ° C., more preferably 120 to 310 ° C., and 120 to 250 ° C. can be exemplified in consideration of safety in use.

  In the present invention, at least one heating element for heating the transpiration liquid agent may be used. However, when increasing the amount of smoke-like chemical transpiration or forming two or more smokes, impregnate the transpiration liquid agent or it. Two or more heating elements may be brought into contact or close to the core material.

  According to the chemical vaporization method of the present invention, the chemical can be evaporated in the atmosphere (for example, indoor space) by heating the vaporized liquid agent through a heating element that generates heat to 100 ° C. or more by energization, and thus The atmosphere (for example, indoor space) can be treated with the drug. Specifically, if a fragrance component is contained in the medicine, the atmosphere (for example, indoor space) can be treated with aroma; if the odor eliminating component is contained in the medicine, the atmosphere (for example, indoor space) is extinguished. Odor treatment can be performed; if a fragrance and a deodorizing component are contained in the medicine, the atmosphere (for example, a store space) can be deodorized and aroma treated. If the drug contains antibacterial components, the atmosphere (eg indoor space) can be treated with antibacterial agents; if the drug contains insect repellent components (anti-mite components), the air (eg indoor spaces) is protected against insects. It can be treated (anti-mite treatment); if insect repellent components are contained in the drug, the atmosphere (eg outdoor and indoor spaces) can be treated with insect repellent.

  Note that when the energization is interrupted (turned off), the heating element is released from the heat generation state and becomes normal temperature (its environmental temperature). By doing so, the transpiration liquid heated by the heat generating element in the heat generation state also returns to normal temperature (its environmental temperature), and its evaporation can be stopped. Although the energization time for one time is not limited, for example, a time for evaporating the 1 to 5 mL capacity of the transpiration liquid agent by evaporating (heating) 60 times can be exemplified. Preferably, the time is 1 to 3 mL capacity, more preferably 1 mL capacity of evaporating liquid that evaporates and disappears by 60 energizations (heating). Although it does not restrict | limit, Specifically, 60 to 600 minutes, Preferably 300 to 400 minutes can be illustrated.

3. Drug evaporation device The drug evaporation device of the present invention is used for carrying out the above-mentioned drug evaporation method.
Specifically, the said chemical vaporizer can illustrate the thing of the following two aspects.

(Aspect 1)
A core material impregnated with the fuming transpiration liquid of the present invention described above;
Having a heating element that is energized and generates heat above 100 ° C .;
The heating element is disposed so as to be in contact with or close to the core material at least when energized, and heats the core material to evaporate the liquid fuming transpiration agent absorbed in the core material in a smoke form.
Drug evaporator.

(Aspect 2)
A container containing the fuming transpiration liquid of the present invention described above;
Inserted into the container, sucking up the liquid fuming transpiration agent from the container, and impregnating the core,
Having a heating element that is energized and generates heat above 100 ° C .;
The heating element is disposed so as to be in contact with or close to the core material at least when energized, and heats the core material to evaporate the liquid fuming transpiration agent absorbed in the core material in a smoke form.
Drug evaporator.

  As shown in FIG. 1, in the chemical vaporizer of the first aspect, the core material 1 impregnated with the vaporized liquid agent containing the chemical is held by the support 3, and the heating element 2 is in contact with or close to the core material 1. It can comprise so that it may have a structure part. In the case of a chemical vaporizer having such a structure, the core material impregnated with the vaporized liquid agent or the support holding the core material can be detached from the chemical vaporizer, and the core impregnated with the vaporized liquid agent after use. It can also be configured such that the material or the core material can be exchanged together with the support holding the core material.

Further, as shown in FIG. 2, the chemical vaporizer of aspect 2 includes a container (container) 4 containing a vaporized liquid agent 5 containing a medicine, and the core material 1 sucks up the vaporized liquid agent 5 accommodated in the container. Even if the core material 1 is fixed and held by the support 3 to the container 4 and has a structure in which the heating element 2 is in contact with or close to the core material 1. Good.
1 and 2, the heating element 2 is described as an example of a heating wire. However, in the chemical vaporizer of the present invention, the heating element is not limited to the heating wire.

  Further, the chemical vaporizer of the present invention comprises means for generating heat from the heating element, that is, a conductive wire for conducting the heating element, and voltage applying means for applying electric power to the heating element. May be.

Hereinafter, an embodiment of the chemical vaporizer of the present invention will be described with reference to the drawings.
<1. Overall structure of chemical vaporizer>
FIG. 3 is a perspective view showing the overall configuration of the chemical evaporator A according to the present embodiment. As shown in the figure, the chemical evaporator A is a chemical evaporator that simulates an incense holder, and has a circular bowl-shaped main body 10 and a pseudo incense stick 15 that is set up on the main body 10. . The pseudo incense stick 15 is not a real incense stick but a plastic stick body imitating an incense stick. More specifically, it is an optical fiber made of acrylic resin, and a green film is pasted on the surface except for the upper end portion 15a. This film is light-impermeable. And the lower end part of the pseudo incense stick 15 similarly arrange | positioned in the main-body part 10 is illuminated by the LED light source 16 arrange | positioned in the main-body part 10 (refer FIG. 14). Thereby, only the upper end part 15a of the pseudo incense stick 15 shines, and an appearance as if a real incense stick is burned is obtained.

  Moreover, the chemical vaporizer A can raise the smoke of the vaporized liquid agent, and in this sense, it can also exhibit a function like an incense holder. The transpiration liquid agent can be a drug having a fragrance component, a deodorant component, an antibacterial component, an insect repellent component, and / or an insect repellent component, etc. Have.

  The transpiration liquid agent is accommodated in a cartridge type container 40 set in the main body 10. FIG. 4 shows the main body 10 in a state in which a flap member 20 that is provided at the upper part of the main body 10 and can be opened and closed by rotation is opened. The container 40 can be set in the space S1 appearing at the upper center of the main body 10 by opening the flap member 20, and can be taken out from here. FIG. 5 is a perspective view of the main body 10 with the flap member 20 omitted for reference, and FIG. 6 is a perspective view showing a state in which the container 40 of the transpiration liquid agent is accommodated in the central space S1 of the main body 10. It is. In FIG. 6, the flap member 20 is omitted for reference.

  FIG. 7 is a perspective view of the container 40. A dedicated cap 45 is attached to the container 40 so that the transpiration liquid does not leak when not in use. Then, the cap 45 is removed at the time of use (see FIG. 8), and is set in the main body 10.

<2. Container section of chemical vaporizer>
The configuration of the container 40 of the chemical vaporizer A will be described in detail. 9 is a cross-sectional view taken along the line AA in FIG. As shown in FIGS. 7 to 9, the container 40 has an open container 41 at the top, and further, around the lower part of the cylindrical side wall portion 42 of the container 41 in order to stably support the container 41. A pedestal 43 is supported from the outside of the container 41. A lid 50 that closes the opening is attached to the upper opening of the container 41. The lid 50 has a substantially flat bottom surface portion 51 and an outer peripheral wall 52 standing along the outer periphery of the bottom surface portion 51. The bottom surface portion 51 and the outer peripheral wall 52 are generally dish-shaped dish portions. 53. The bottom surface portion 51 defines the upper surface of the internal space S2 of the container 41. The container 41 is filled with the above-mentioned transpiration liquid.

  A circular opening S3 is formed at the center of the bottom surface portion 51, and a cylindrical body 54 having an internal space communicating with the opening S3 is continuous with the lower surface of the bottom surface portion 51. The cylindrical body 54 is spaced apart from the bottom surface portion 44 of the container 41 and extends generally in the vertical direction. The core member 60 is inserted into the cylindrical body 54 through the opening S3 so that the lower end 60a reaches the bottom surface portion 44 in general. On the other hand, the upper end 60 b of the core member 60 protrudes from the bottom surface portion 51 of the lid 50 so as to be in contact with or close to a heating element 65 described later. The core member 60 is a rod having substantially the same cross-sectional shape as that of the opening S3 and the cylindrical body 54, and can be impregnated with the transpiration liquid agent in the container 41.

  As shown in FIG. 8, an opening S <b> 4 communicating with the internal space S <b> 2 of the container 41 is formed in the bottom surface portion 51 of the dish portion 53 in addition to the opening S <b> 3 into which the core member 60 is inserted. Although details will be described later, a tunnel passage S5 in which condensation of the heated and evaporated smoke-like transpiration liquid agent is arranged above the bottom surface portion 51 of the plate portion 53. Therefore, the dish part 53 can function as a member for receiving the liquid vaporized liquid falling from the tunnel passage S5 after dew condensation in the tunnel passage S5. The plurality of openings S <b> 4 in the bottom surface portion 51 function as a liquid return passage for returning the liquid transpiration agent received by the dish portion 53 to the internal space S <b> 2 of the container 41.

  A spiral thread 42 a is formed on the upper outer peripheral surface of the side wall portion 42 of the container 41. The thread 42a is screwed into a screw groove (not shown) formed in the cap 45 of the container 40, so that the cap 45 can be attached to and detached from the container 40.

  A handle 46 is continuous with the base 43 of the container 41. The handle 46 extends substantially parallel to the side wall part 42 with a certain distance from the side wall part 42, and extends above the core member 60 held by the lid 50. The handle 46 is used to carry the container 40 when the container 40 is accommodated in the space S <b> 1 provided in the upper center of the main body 10.

  Although the material of the container 40 and the cap 45 is not specifically limited, For example, it can be made from plastics (except for the core material 60). The container 40 can be configured integrally with the above-described parts, or can be configured by combining separate members.

<3. Main unit>
The main body 10 includes a housing 11 that forms an outer wall shaped like an incense holder, and a space S <b> 1 for accommodating the container 40 is formed in the upper center. The main body 10 further includes a flap member 20 that is accommodated in the space S <b> 1 from above the container 40. The flap member 20 is swung by rotation and can open and close the space S1. Although the material of the housing | casing 11 is not specifically limited, For example, it can be made from plastics.

  FIG. 10 is a perspective view of the single flap member 20 viewed from the upper surface side, and FIG. 11 is a perspective view of the single flap member 20 viewed from the lower surface side. As shown in the figure, the flap member 20 has a rectangular parallelepiped shape, and a rotation shaft 21 for rotating the flap member 20 is provided in parallel with the short direction at one end in the longitudinal direction. As shown in FIG. 5, the space S <b> 1 has a shape in which a rectangular parallelepiped is stacked on the upper part of the cylinder in such a manner as to protrude in the radial direction from the cylinder. Further, the upper surface of the cylinder and the upper surface of the rectangular parallelepiped here are substantially the same height, and only the longitudinal direction of the rectangular parallelepiped protrudes from the side surface of the cylinder and does not protrude in the lateral direction. The rectangular parallelepiped has substantially the same shape as the flap member 20, and the space S1 can receive the flap member 20 at a portion corresponding to the rectangular parallelepiped. Moreover, the housing | casing 11 is supporting the rotating shaft 21 so that the flap member 20 may be rotated up and down in the part corresponding to the end of the longitudinal direction of this rectangular parallelepiped in space S1. Hereinafter, a state in which the flap member 20 is accommodated in a portion corresponding to the rectangular parallelepiped of the space S1 is referred to as a state in which the flap member 20 is closed. Further, on the upper surface of the flap member 20, a handle 22 protrudes from an end portion on the opposite side of the rotation shaft 21. The user can easily turn the flap member 20 around the turning shaft 21 by hooking a finger on the handle 22.

  The space S1 communicates with the external space even when the flap member 20 is closed. That is, openings S7 and S7 (see FIG. 3) communicating with the space S1 are secured on both sides of the flap member 20. Further, a protrusion 24 projects from an end surface of the flap member 20 opposite to the side on which the rotation shaft 21 is provided. On the other hand, an elastic piece 23 for hooking the protrusion 24 is provided at a portion of the main body 10 that receives a portion near the end face of the flap member 20 (see FIG. 5). When the flap member 20 is to be closed, the projection 24 presses the elastic piece 23, and the elastic piece 23 is elastically deformed so as to be bent radially outward. After that, when the flap member 20 is accommodated in the space S1, the elastic piece 23 generally returns to its original shape due to its elasticity and presses the protrusion 24 from above. Thereby, the flap member 20 is firmly fixed in the space S1 and locked in the closed state. On the other hand, even when an external force is applied to the flap member 20 by holding the handle 22 to rotate the entire flap member 20 upward, the elastic piece 23 is elastically deformed so as to be bent radially outward, and the flap member 20. Can be opened easily.

  In the center of the flap member 20, a tunnel passage S5 that penetrates the flap member 20 in the generally vertical direction is formed. More specifically, in the center of the flap member 20, a cylindrical tunnel member 30 having openings at both ends that define the tunnel passage S5 is embedded. The tunnel member 30 may be formed integrally with the rectangular parallelepiped housing of the flap member 20. Hereinafter, the opening at the lower end of the tunnel member 30 communicating with the tunnel passage S5 is referred to as a tunnel inlet 30a, and the opening at the upper end is referred to as a tunnel outlet 30b.

  In the tunnel passage S5, a heating element 65 is disposed for heating the core member 60 and evaporating the transpiration liquid absorbed in the core member 60 into a smoke form (see FIG. 9). The heating element 65 is a heating wire that generates heat when energized. The heating element 65 is a position on the inner wall surface 31 of the tunnel member 30 and another position on the inner wall surface 31 facing the tunnel member 30 (both positions are the positions of the tunnel member 30). (Located on the diameter line of the circular cross section). The heating element 65 is disposed below the center in the vertical direction in the tunnel passage S5. Both ends of the heating element 65 are wired to the battery 8 described later. In addition, this wiring is accommodated in the position which is not normally touched from the outside in the flap member 20 and the housing | casing 11. FIG. With the above configuration, the tunnel passage S5 becomes a passage through which the smoke-like transpiration liquid agent generated by heating the heating element 65 passes.

  As shown in FIG. 11, a plurality of wall members 34 (four in the present embodiment) extend downward from the lower portion of the tunnel member 30 so as to surround the tunnel inlet 30a. The lower ends of these wall members 34 come into contact with the bottom surface portion 51 of the plate portion 53 constituting the upper portion of the container 40 in a state where the container 40 is accommodated in the space S1 of the main body portion 10 and the flap member 20 is closed. . That is, the container 40 is arranged at a certain interval in the vertical direction from the tunnel entrance 30a, and the wall member 34 is arranged so as to extend between the tunnel entrance 30a and the container 40 so as to fill this interval. The container 40 is disposed immediately below the tunnel entrance 30a, and the center of the bottom surface portion 51 of the container 40 and the center of the tunnel entrance 30a substantially overlap in plan view. The lower part of the outer surface of the wall member 34 is in contact with the inner peripheral surface of the outer peripheral wall 52 of the dish portion 53.

  FIG. 12 is a bottom view of the vicinity of the tunnel member 30. As shown in FIGS. 11 and 12, the wall members 34 are arranged at equal intervals while leaving a gap S6 along the circumferential direction of the tunnel entrance 30a. This gap S6 is vacated by the same length at equal intervals, and serves as an air inlet for sending air into the tunnel passage S5 via the tunnel inlet 30a. That is, since the space below the tunnel entrance 30a is surrounded by the wall member 34 and the plate portion 53 of the container 40 except for the gap S6, in principle, only the gap S6 takes air into the tunnel passage S5. It becomes an inlet. The external air first flows into the space S1 in the main body 10 through the openings S7 and S7 formed at both ends of the flap member 20, and this is sent into the tunnel passage S5 through the gap S6. .

  As shown in FIG. 12, a plurality of convex portions 32 projecting inward in the radial direction are formed on the inner wall surface 31 of the tunnel member 30 that defines the tunnel passage S5. These convex portions 32 are provided at different positions along the circumferential direction of the inner wall surface 31. In the present embodiment, the same number of projections 32 as the wall members 34, that is, four projections 32 are provided, and these projections 32 are arranged at approximately equal intervals along the circumferential direction of the inner wall surface 31. Moreover, the convex part 32 is continuously extended in the up-down direction from the same height position as the tunnel exit 30b through the tunnel entrance 30a to slightly above the lower end of the wall member 34. Further, below the tunnel entrance 30a, the convex portion 32 is connected to the wall member 34 and protrudes radially inward from the center of the inner wall surface of the wall member 34 in plan view. . Moreover, although the convex part 32 is extended in the radial direction of the circular cross section of the inner wall surface 31 from the inner wall surface 31 in planar view, it has not reached the center of the circular section. Therefore, an open space extending in the vertical direction is formed in the center of the tunnel passage S5 without being obstructed by the convex portion 32.

  The convex portion 32 configured as described above can prevent a finger from touching the heating element 65 in the tunnel passage S5. Moreover, the convex part 32 can play the role which raises the smoke-like transpiration | evaporation liquid agent evaporated by the heating by the heat generating body 65 more finely in addition to this role. FIG. 13 is a schematic longitudinal sectional view in the vicinity of the tunnel passage S5 for explaining the role of the convex portion 32. As shown in FIG. That is, in the tunnel passage S5, as the air is warmed by the heating element 65, a gentle updraft is generated. The smoke composed of aerosol particles of the transpiration liquid agent generated by heating the upper end 60b of the core member 60 by the heating element 65 rises while passing through the tunnel passage S5 on this rising airflow. While colliding with the inner wall surface 31, it also collides with the convex part 32. Thereby, the evaporation liquid agent is condensed on the surfaces of the inner wall surface 31 and the convex portion 32, and droplets adhere. The adhesion amount of droplets, that is, aerosol particles, increases as evaporation of the evaporation liquid progresses, and accordingly, the evaporation liquid drops adhering to the surfaces of the inner wall surface 31 and the convex portion 32 cause the evaporation liquid. The tunnel passage S5 through which smoke passes is substantially narrowed. As a result, the speed of the ascending air flow increases, and the evaporated liquid transpiration agent rises thinner and higher. Moreover, since the convex part 32 has continued in the up-down direction within the tunnel passage S5, it is easy for air to flow straight upward. That is, for example, when the convex portion 32 is interrupted in the middle, the air current is bent at the disconnected portion of the convex portion 32, but such a situation is avoided in the present embodiment.

  By the way, the above ascending air current is formed by the air flowing in from the gap S6 described above. Further, as described above, due to the presence of the wall member 34, the air suction port into the tunnel passage S5 is narrowed, and the air suction port is mainly only the gap S6. Therefore, a higher-speed airflow flows into the tunnel passage S5 through the narrowed gap S6 as the air suction port, resulting in a higher and higher smoke-like transpiration liquid. In addition, the tunnel through which the evaporated transpiration agent passes is substantially extended by the presence of the wall member 34. As a result, the chimney effect is promoted, and the evaporated transpiration liquid rises higher.

There are four gaps S6, but the area per one is preferably 2 mm ^{2 to} 40 mm ² , more preferably 4 mm ^{2 to} 30 mm ² , still more preferably 4 mm ^{2 to} 20 mm ² , and even more preferably 5 mm ^2. it is a ~15mm ^2. The gap S <b> 6 here is a region surrounded by the tunnel member 30 on the upper side, a pair of wall members 34 on the left and right sides, and the outer peripheral wall 52 of the dish part 53 on the lower side. On the other hand, space S7, has provided two positions, the area per one is preferably 150 mm ² to 300 mm ^2, more preferably 200 mm ² to 300 mm ^2. Here, the space S7 is an area surrounded on the inner side by the flap member 20 and on the outer side by the upper surface 13 of the housing 11a. Further, the tunnel inlet 30a and the tunnel outlet 30b (i.e., the inner cross-sectional shape of the wall 31 of the tunnel member 30) (including the convex portion 32) area is preferably 20mm ² ~180mm ^2, more preferably 50mm ² ~120mm ² , even more preferably 50 mm ² 100 mm ^2. External air first flows into the space S1 in the main body 10 through the openings S7 and S7 formed at both ends of the flap member 20, and is sent into the tunnel passage S5 through the gap S6. As a result, the wind speed increases stepwise from the external space into the space S1 through the space S7 and then into the tunnel member 30 from the space S1 through the gap S6. Further, smoke is emitted from the tunnel member 30 to the external space through the tunnel outlet 30b at a wind speed of a certain level or higher. When each area is in the numerical range as described above, the effect can be further exhibited.

  Further, the size of the particles of the transpiration liquid agent generated in the tunnel passage S5 varies in size, but smaller particles can flow faster and rise higher. Also, larger particles are easier to see. Then, as shown in FIG. 13, since the smaller particles collide with the larger aerosol particles and give an upward force thereto, even the larger particles can rise higher. Therefore, easily visible smoke containing large aerosol particles rises thinner and higher.

  Further, as described above, the aerosol particle diameter of the transpiration liquid agent adhering to the surfaces of the inner wall surface 31 and the convex portion 32 increases as the evaporation liquid agent evaporates and gradually grows. The increased droplets of the transpiration liquid fall along the inner wall surface 31, the convex portion 32 and the wall member 34 according to gravity and are received by the dish portion 53. The liquid evaporation liquid collected in the dish part 53 is returned to the internal space S2 of the container 40 through the opening S4 of the bottom part 51. Therefore, various problems such as dirt caused by condensation of the transpiration liquid and waste of the transpiration liquid are eliminated.

  Returning to FIG. 5, the lower surface of the space S <b> 1 of the main body 10 described above is defined by a tray 55 that can be moved up and down in the vertical direction. The saucer 55 is substantially equal to the outer shape of the lower portion of the container 40 and defines a space in which it can be accommodated. 14 is a cross-sectional view taken along line BB in FIG. As shown in the figure, the raising / lowering of the tray 55 is realized by a spring 56 connected to the lower side of the tray 55. When the tray 55 receives an external force from above, the spring 56 contracts and the tray 55 moves downward. In addition, if the flap member 20 is closed in the state which accommodated the container 40 in the saucer 55, the saucer 55 will be pushed by the container 40 and will move below. At this time, the spring 56 urges the tray 55 upward by the restoring force, and as a result, the container 40 is urged against the tunnel member 30 via the wall member 34. Thereby, the bottom face part 51 and the outer peripheral wall 52 of the dish part 53, and the wall member 34 fit firmly, and the position of the container 40 in space S1 is stabilized. This also makes it difficult for gaps other than the gap S6 to form as an air suction port communicating with the tunnel passage S5 below the tunnel entrance 30a.

  By the way, the housing | casing 11 can be divided | segmented into two upper and lower housing | casing 11a, 11b along the dividing line L1 shown in FIG. FIG. 15 is a view of the upper casing 11a as seen from the bottom side. As shown in the figure, a battery housing portion 80 to which two batteries 8 can be attached is provided outside the bottom surface portion of the upper casing 11a.

  FIG. 15 is a block diagram showing an electrical configuration of the chemical vaporizer 1. As shown in the figure, the battery 8 is electrically connected to the heating element 65 and the LED light source 16, and supplies power thereto. As shown in FIG. 14, the LED light source 16 is disposed immediately below the opening S8 that receives the pseudo-incense stick 15 in the housing 11a. A control board 18 connected to the switch 17 is also housed in the upper casing 11a. As shown in FIG. 3, a switch 17 is disposed on the upper surface 13 of the housing 11 a, and when the switch 17 is pressed, a signal indicating that is sent to the control board 18. The control board 18 is connected to a detection circuit 19 that detects that the spring 56 is pressed. When the control board 18 detects that the spring 56 is in a pressed state (the container 40 is set in the space S1 and the flap member 20 is closed) and the switch 17 is pressed in the power-off state. Then, power is supplied from the battery 8 to the heating element 65 and the LED light source 16. On the other hand, when the switch 17 is pressed in the power-on state or when the spring 56 is released, the power supply from the battery 8 to the heating element 65 and the LED light source 16 is stopped.

  As shown in FIG. 3, the upper surface 13 of the housing 11 is formed in an annular shape so as to define a space S1. And three openings S8 for inserting the pseudo incense stick 15 are formed on the front side of the upper surface 13. On the other hand, the switch 17 is arranged on the upper surface 13 of the housing 11 on the side opposite to the opening S8 by approximately 180 °. An outer wall portion 14 stands on the annular upper surface 13 along the outer peripheral edge thereof. The outer wall portion 14 is a part that defines the edge of the upper opening of the bowl-shaped casing 11. The upper surface 13 of the housing 11 is located in substantially the same plane as the upper surface of the flap member 20 in a closed state, in other words, is disposed at the same height as the tunnel outlet 30b. Therefore, the outer wall part 14 acts as a windbreak against the smoke rising from the tunnel exit 30b, and helps the smoke rise straight and straight. Further, the outer wall portion 14 is formed substantially continuously around the upper surface 13 of the housing 11, but is notched at a position facing the switch 17 so as not to hinder the operation of the switch 17. It is. Furthermore, even when the chemical evaporator 1 is turned over and turned upside down, the outer wall portion 14 prevents the switch 17 from malfunctioning.

  FIG. 17 is a bottom view of the chemical evaporator A. As shown in the figure, the casing 11 is provided with three legs 29 around the central axis of the casing 11 at equal angular intervals. One of these three legs 29 is arranged around the central axis of the housing 11 at the same angle as the switch 17. In FIG. 17, the position of the switch 17 is indicated by a dotted line for reference. By the way, when the switch 17 is pressed, a non-uniform external force is applied to the housing 11 around the switch 17. However, according to the said structure, since the leg 29 corresponding to the switch 17 supports the housing | casing 11 firmly, the chemical vaporizer A does not fall down.

  In the above description, the wall member 34 is integrally formed with the tunnel member 30, but is not formed with the tunnel member 30, but is formed integrally with the outer peripheral wall 52 of the container portion 53, for example, the dish portion 53. Also good. Alternatively, the wall member 34 may be a component independent of both the tunnel member 30 and the container 40.

  Moreover, the shape of the convex part 32 is not restricted to what was mentioned above. For example, the convex part 32 is good also as a shape which complete | finished in the tunnel entrance vicinity from tunnel exit 30b vicinity. Moreover, the number of the convex parts 32 is not restricted to four, For example, one may be sufficient. Further, as shown in FIG. 18A, the convex portion 32 may reach the center of the tunnel passage S5 in a plan view, and in this case, the plurality of convex portions 32 may intersect at the center. . Moreover, as shown in FIG.18 (b), it is good also as a grid | lattice form in planar view. However, in the form shown in FIGS. 18A and 18B, the tunnel passage S5 is divided into a plurality of passages, so that the passage may be partially filled by condensation. Therefore, the form shown in FIG. 12 is preferable from the viewpoint of raising one thin long smoke.

<3. Usage>
Hereinafter, the method of using the chemical vaporizer A will be described. First, the main body part 10, the container 40, and the pseudo incense stick 15 which comprise the chemical vaporizer A are prepared. And the flap member 20 of the main-body part 10 is rotated, the space S1 is opened, the handle 46 is grasped, the container 40 is inserted, and then the flap member 20 is closed. At this time, in the tunnel passage S <b> 5 of the flap member 20, the core member 60 of the container 40 is arranged so as to be in contact with or close to the heating element 65. Further, the pseudo incense stick 15 is inserted into the opening S8 of the upper surface 13 of the main body 10.

  Thereafter, when the switch 17 is pressed, the heating element 65 and the LED light source 16 are energized, the heating element 65 is heated, and the LED light source 16 is turned on. The light from the LED light source 16 travels through the pseudo-incense stick 15 and reaches the upper end 15a to generate colored light. Further, after a while after the switch 17 is pressed, the transpiration liquid agent impregnated in the core member 60 is heated, and a smoke-like transpiration liquid agent visible from the upper end 60 b of the core member 60 starts to be generated. The smoke starts to rise long and narrow along the flow of air flowing into the tunnel passage S5 through the gap S6 formed between the container 40 and the wall member 34. After a while, condensation of the transpiration liquid begins to occur in the tunnel passage S5. This droplet grows on the inner wall surface 31, the convex portion 32, and the surface of the wall member 34 of the tunnel member 30, and substantially narrows the tunnel passage S5, thereby causing the rising airflow generated in the tunnel passage S5. Increase speed. In response to this, the smoke coming out from the tunnel exit 30b rises upwards more and more thinly.

  Further, a part of the droplet that has grown greatly in the tunnel passage S5 falls according to gravity. The droplets of the transpiration liquid that have fallen are received by the dish 53 at the top of the container 40, move into the container 40 through the opening S 4, and are sucked up by the core member 60 again.

  As described above, the chemical vaporizer A can be used as a pseudo incense holder. In particular, it is excellent in safety in that the light, smoke and scent of incense can be realized without using fire.

  Hereinafter, although the present invention will be described with reference to test examples and examples, the present invention is not limited to these test examples and examples.

Test example 1
Using the solvents and fragrances shown in Table 1 as test samples (liquid transpiration agents), the amount of evaporation during heating, the amount of volatilization during non-heating (natural evaporation), and the presence or absence of smoke during heating were measured.
Specifically, about 0.5 g of each test sample (Reference Examples 1 to 6) was impregnated into a cylindrical core material (outer diameter 5 mm, height 10 mm) made of glass fiber. Next, the core material impregnated with the test sample is a chemical vaporizer having the same main parts as in FIG. In addition, the chemical evaporator used for transpiration of the test sample in Table 1 has a structure in which one heating wire is brought into contact with one core material.), And the apex of the core material and the evaporator The heating element was brought into contact. This was placed in a 30 cm ³ volume sealable box, the box was sealed, connected to a constant voltage device set at 3 V, the power was turned on, and the heating element was heated to 200 ° C. The state where the power was turned on was maintained for 30 seconds, and the transpiration state of the test sample was observed to examine whether smoke (aerosol) was generated. The power source was turned off and left for 30 seconds to cool the heating element (heating wire) and each test sample. Thereafter, the power was turned on again and held for 30 seconds, the heating element was heated to 200 ° C., and the test sample was evaporated. This was repeated 60 times in total, and the transpiration amount (g) of the test sample per heating was determined from the disappearance amount of the test sample.

  On the other hand, 0.5 g of each test sample was impregnated into a cylindrical core material made of glass fiber in the same manner as described above, placed in a constant temperature and humidity condition (27 ° C., 60%), and left for 2 months. From the transpiration amount (disappearance amount) during this period (calculated from the weight difference before and after leaving the core material impregnated with the test sample), the ratio (%) of the disappearance amount to the total amount of the initial test sample (% natural evaporation rate) was determined.

Smoke (aerosol) is generated by evaporation when heated, the transpiration amount of one heating is in the range of 0.025 g or more, and the natural evaporation rate is 5% or less. The case where any one of them was not satisfied was judged as defective x. The results are also shown in Table 1.

  From the above results, a test sample having a boiling point of the solvent of 170 ° C. or higher, an average vapor pressure at 20 ° C. of 0.1 to 10 Pa, and an average molecular weight of the soluble component of 150 to 250 evaporates when heated to 100 ° C. or higher. Smoke was generated, the amount of transpiration once heated was in the range of 0.025 g or more, and the natural evaporation rate was 5% or less.

Test example 2
Based on the results of Test Example 1, the mixed liquid of the solvent and the fragrance shown in Table 2 was used as a test sample (liquid transpiration agent) (Examples 1 to 4 and Comparative Examples 1 and 2), and the same as Test Example 1 By the method, the evaporation amount at the time of heating, the volatilization amount at the time of non-heating (natural evaporation amount), and the presence or absence of smoke generation at the time of heating were measured.

The results are also shown in Table 2.

  From the above results, the test sample having a solvent boiling point of 170 ° C. or higher, an average vapor pressure at 20 ° C. of 0.1 to 10 Pa, and an average molecular weight of 150 to 250 evaporates and smokes when heated to 100 ° C. or higher. The amount of transpiration generated once was in the range of 0.025 g or more, and the natural evaporation rate was 5% or less.

DESCRIPTION OF SYMBOLS 1 Core material impregnated with liquid fuming transpiration agent 2 Heat generating body 3 Support body 4 Container 5 Liquid fuming transpiration agent 8 Battery 8
DESCRIPTION OF SYMBOLS 10 Main body part 11 Case 13 Upper surface 14 of case 11a Pseudo-incense stick 16 LED light source 17 Switch 18 Control board 19 Detection circuit 20 Flap member 21 Rotating shaft 22 Handle 23 Elastic piece 24 Protrusion 30 Tunnel member 30a Tunnel entrance 30b Tunnel exit 31 Inner wall surface 32 Convex portion 34 Wall member 40 Container 41 Container 42 Side wall portion 42a Spiral thread 43 Base 44 Bottom surface 45 Cap 46 Handle 50 Lid 51 Bottom surface 52 Outer wall 53 Dish 54 Tube 56 Spring (biasing member)
60 Core 65 Heating element (heating unit)
S2 Inner space S3 of container 41 Opening S4 Opening (liquid return passage)
S5 Tunnel passage S6 Clearance (air inlet)

Claims (9)

(A) a liquid fuming transpiration agent containing a drug and a solvent,
(B) the boiling point of the solvent is 170 ° C. or higher,
(C) The average vapor pressure of the transpiration liquid at 20 ° C. is 0.1 to 10 Pa,
(D) The average molecular weight of the soluble component contained in the transpiration liquid is 150 to 250,
A liquid fuming transpiration agent, characterized in that   The liquid fuming transpiration agent according to claim 1, wherein the drug contains at least one selected from the group consisting of a fragrance component, a deodorant component, an insecticide component, an antibacterial component, and an insect repellent component.   A core material obtained by impregnating a porous substrate with the liquid fuming transpiration agent according to claim 1.   The liquid fuming transpiration agent according to claim 1 or 2, or the core material according to claim 3, which is sealed in a liquid-tight and air-tight package.   The liquid fuming transpiration agent according to claim 1 or 2, or a core material impregnated with a porous base material, is supplied to a heating element that generates heat at 100 ° C or more by energization, and heated, thereby A chemical transpiration method or a spatial treatment method using a chemical, comprising a step of transpiration of a liquid fuming transpiration agent into a smoke form.   6. The chemical transpiration method or the chemical space treatment method according to claim 5, wherein the boiling point of the solvent contained in the liquid fuming transpiration agent is 170 to 350 ° C., and the exothermic temperature of the heating element is 100 to 350 ° C. A core material impregnated with the liquid fuming transpiration agent according to claim 1 or 2,
Having a heating element that is energized and generates heat above 100 ° C .;
The heating element is disposed so as to be in contact with or close to the core material at least when energized, and heats the core material to evaporate the liquid fuming transpiration agent absorbed in the core material in a smoke form.
Drug evaporator. A container containing the liquid fuming transpiration agent according to claim 1 or 2,
Inserted into the container, sucking up the liquid fuming transpiration agent from the container, and impregnating the core,
Having a heating element that is energized and generates heat above 100 ° C .;
The heating element is disposed so as to be in contact with or close to the core material at least when energized, and heats the core material to evaporate the liquid fuming transpiration agent absorbed in the core material in a smoke form.
Drug evaporator.   The chemical vaporizer according to claim 7 or 8, wherein the liquid fuming transpiration agent contains at least a fragrance component having a scent of incense as a chemical, and is used as an electric pseudo-incense device.